ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2018

Jun 1, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2018-05-30

Reporting Person: Myszkowski Kenneth Allen (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-30	Common Stock	M	1400	$2.01	Acquired	312215	Direct
2018-05-30	Common Stock	S	1400	$11.00	Disposed	310815	Direct
2018-05-31	Common Stock	M	12600	$2.01	Acquired	323415	Direct
2018-05-31	Common Stock	S	12600	$11.00	Disposed	310815	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-30	Stock Option (right to buy)	$2.01	M	1400	Disposed	2023-05-06	Common Stock (1400)	Direct
2018-05-31	Stock Option (right to buy)	$2.01	M	12600	Disposed	2023-05-06	Common Stock (12600)	Direct

Footnotes

F1: Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2: Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.

F3: Represents first vesting date. Option vests over four years from date of grant.